Senior insider sale
President & CEO at ULTRAGENYX PHARMACEUTICAL INC. — senior position signals high conviction
$3.04M
77.85K shares
What this filing means
KAKKIS EMIL D plans to sell 77.85K shares of ULTRAGENYX PHARMACEUTICAL INC. valued at approximately $3.04M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 12/29/2023ACC: 0002002698-23-000203
DirectorOfficer· President & CEO
Since Mar 2026
77.85K
Shares to sell
$3.04M
Approx. market value
30K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months12
RSU VESTING
CASH
3/2/2020
4.04KRSU VESTING
CASH
6/3/2019
1.35KRSU VESTING
CASH
5/21/2019
1.44KRSU VESTING
CASH
4/22/2019
917.00RSU VESTING
CASH
3/1/2019
5.24KRSU VESTING
CASH
6/1/2018
1.75KRSU VESTING
CASH
5/21/2018
1.86KRSU VESTING
CASH
3/1/2018
2.14KRSU VESTING
CASH
8/28/2017
6.05KRSU VESTING
CASH
6/1/2017
1.67KRSU VESTING
CASH
5/22/2017
1.78KRSU VESTING
CASH
5/20/2016
1.78KTotal acquired30K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/2/2020 | RSU VESTING CASH | 4.04K | — |
6/3/2019 | RSU VESTING CASH | 1.35K | — |
5/21/2019 | RSU VESTING CASH | 1.44K | — |
4/22/2019 | RSU VESTING CASH | 917.00 | — |
3/1/2019 | RSU VESTING CASH | 5.24K | — |
6/1/2018 | RSU VESTING CASH | 1.75K | — |
5/21/2018 | RSU VESTING CASH | 1.86K | — |
3/1/2018 | RSU VESTING CASH | 2.14K | — |
8/28/2017 | RSU VESTING CASH | 6.05K | — |
6/1/2017 | RSU VESTING CASH | 1.67K | — |
5/22/2017 | RSU VESTING CASH | 1.78K | — |
5/20/2016 | RSU VESTING CASH | 1.78K | — |
| Total | 30K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
47.85K
Market value
$1.60M
10/19/2023
Planned — Approximate Date
NASDAQPlanned
Units to sell
30K
Market value
$1.44M
12/29/2023
Total
Units
77.85K
Value
$3.04M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/19/2023 | 47.85K | $1.60M | — | Completed |
| Planned — Approximate Date | ||||
12/29/2023 | 30K | $1.44M | NASDAQ | Planned |
| Total | 77.85K | $3.04M | ||